490 related articles for article (PubMed ID: 37509136)
1. Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis.
Bonzano L; Borgia F; Casella R; Miniello A; Nettis E; Gangemi S
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509136
[TBL] [Abstract][Full Text] [Related]
2. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
[TBL] [Abstract][Full Text] [Related]
3. Microbial dysbiosis in a mouse model of atopic dermatitis mimics shifts in human microbiome and correlates with the key pro-inflammatory cytokines IL-4, IL-33 and TSLP.
Amar Y; Schneider E; Köberle M; Seeholzer T; Musiol S; Hölge IM; Gschwendtner S; Krappmann D; Steiger K; Biedermann T; Schmidt-Weber CB; Alessandrini F
J Eur Acad Dermatol Venereol; 2022 May; 36(5):705-716. PubMed ID: 35015907
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Microbiota in the Pathogenesis and Treatment of Atopic Dermatitis-A Literature Review.
Wrześniewska M; Wołoszczak J; Świrkosz G; Szyller H; Gomułka K
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928245
[TBL] [Abstract][Full Text] [Related]
5. IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis.
Bodoor K; Al-Qarqaz F; Heis LA; Alfaqih MA; Oweis AO; Almomani R; Obeidat MA
Clin Cosmet Investig Dermatol; 2020; 13():419-424. PubMed ID: 32606880
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
Werfel T; Allam JP; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon HU; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
J Allergy Clin Immunol; 2016 Aug; 138(2):336-49. PubMed ID: 27497276
[TBL] [Abstract][Full Text] [Related]
7. The role of skin dysbiosis in atopic dermatitis.
Braun C; Patra V; Lina G; Nicolas JF; Vocanson M; Nosbaum A
Eur J Dermatol; 2022 Jul; 32(4):439-444. PubMed ID: 36301755
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis: Pathophysiology, microbiota, and metabolome - A comprehensive review.
Mohammad S; Karim MR; Iqbal S; Lee JH; Mathiyalagan R; Kim YJ; Yang DU; Yang DC
Microbiol Res; 2024 Apr; 281():127595. PubMed ID: 38218095
[TBL] [Abstract][Full Text] [Related]
9. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.
Schäbitz A; Eyerich K; Garzorz-Stark N
J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch.
Li W; Yosipovitch G
Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):44-50. PubMed ID: 32910440
[TBL] [Abstract][Full Text] [Related]
11. IL-31: a new link between T cells and pruritus in atopic skin inflammation.
Sonkoly E; Muller A; Lauerma AI; Pivarcsi A; Soto H; Kemeny L; Alenius H; Dieu-Nosjean MC; Meller S; Rieker J; Steinhoff M; Hoffmann TK; Ruzicka T; Zlotnik A; Homey B
J Allergy Clin Immunol; 2006 Feb; 117(2):411-7. PubMed ID: 16461142
[TBL] [Abstract][Full Text] [Related]
12. IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases.
Borgia F; Custurone P; Li Pomi F; Vaccaro M; Alessandrello C; Gangemi S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613827
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
Tsuji G; Yamamura K; Kawamura K; Kido-Nakahara M; Ito T; Nakahara T
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834081
[TBL] [Abstract][Full Text] [Related]
14. Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.
Beck LA; Bieber T; Weidinger S; Tauber M; Saeki H; Irvine AD; Eichenfield LF; Werfel T; Arlert P; Jiang L; Røpke M; Paller AS
J Am Acad Dermatol; 2023 Apr; 88(4):816-823. PubMed ID: 36473633
[TBL] [Abstract][Full Text] [Related]
15. The skin microbiome: is there a role in the pathogenesis of atopic dermatitis and psoriasis?
Sanchez DA; Nosanchuk JD; Friedman AJ
J Drugs Dermatol; 2015 Feb; 14(2):127-30. PubMed ID: 25689807
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-immune crosstalk with the skin microbiota in homeostasis and atopic dermatitis - a mini review.
Kobayashi T; Imanishi I
Vet Dermatol; 2021 Dec; 32(6):533-e147. PubMed ID: 34378246
[TBL] [Abstract][Full Text] [Related]
17. Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.
Guttman-Yassky E; Nograles KE; Krueger JG
J Allergy Clin Immunol; 2011 Jun; 127(6):1420-32. PubMed ID: 21419481
[TBL] [Abstract][Full Text] [Related]
18. IL-4/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis.
Grolleau C; Calugareanu A; Demouche S; Nosbaum A; Staumont-Sallé D; Aubert H; Cassius C; Jachiet M; Saussine A; Bagot M; Bachelez H; Battistella M; Hotz C; Du Thanh A; Crépy MN; Bergerat D; Merandet M; Onifarasoaniaina R; Alberdi A; How-Kit A; Bouaziz JD; Le-Buanec H
J Invest Dermatol; 2023 May; 143(5):711-721.e7. PubMed ID: 36610660
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 31 and skin diseases: A systematic review.
Gangemi S; Quartuccio S; Casciaro M; Trapani G; Minciullo PL; Imbalzano E
Allergy Asthma Proc; 2017 Nov; 38(6):401-408. PubMed ID: 29046191
[TBL] [Abstract][Full Text] [Related]
20. Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis.
Orfali RL; Aoki V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
